Somalogic Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| – | – | – | – | – | |
| – | -10.6% | -9.0% | +77.9% | +58.1% | |
| – | +16.1% | +87.3% | +53.5% | -44.8% | |
| – | +94.2% | +47.1% | -64.5% | – | |
| – | – | – | +392.9% | -144.0% | |
| – | +70.1% | +481.6% | -22.5% | -11.1% | |
| – | -131.1% | +1,844.7% | – | – | |
| – | – | – | -98.6% | – | |
| – | +0.0% | -1,137.3% | – | – | |
| – | +130,987.5% | +163.5% | -99.0% | -86.1% | |
| – | – | +82.3% | -104.7% | – | |
| – | – | – | – | – |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.